Welcome to Medafor Hemostatic Polymer Technologies

Medafor, Inc., Announces the Formation of Its Medical Advisory Board
Minneapolis, Minn., June 2000 - Medafor, Inc., announces the establishment of its Medical Advisory Board of leading experts in hematology, wound management, trauma surgery, dermatology, vascular surgery and medical device regulations. READ FULL STORY.

Patent Awarded to Medafor, Inc., for Topically Applied Blood Clotting Methods
Minneapolis, Minn., May 2000 - Recognizing the distinctive qualities of Medafor's innovative technology, the U.S. Patent Office has issued protection covering 31 method claims for producing hemostasis using microporous particles. READ FULL STORY.

2006

Chicago, Illinois
112th Annual Meeting and OTO Expo, American Academy of Otolaryngology
September 21-24, 2008

San Francisco, California
94th Annual Clinical Congress, American College of Surgeons
October 12-16, 2008

Medafor, Inc., was founded in 1999 to develop and market applications for its patented MPH® (Microporous Polysaccharide Hemospheres Technology). Statements presented on this page have not been evaluated by the U.S. FDA. See respective Instructions for Use for product applications and indications. Site content and images Copyright 2008 Medafor, Inc. All Rights Reserved. No part of this site may be copied, republished, excerpted or transferred to other media without the express written consent of Medafor, Inc. Arista™AH, MPH®, Medafor®, MPatcH®, FlexiTip™ are trademarks of Medafor, Inc. Other trademarks mentioned are the property of their respective companies. For information, contact Medafor at 1-763-571-6300.